|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization expense | |||||
| Change in fair value of derivative liability associated with contingently issuable warrants | |||||
| Non-cash interest expense related to term loan | |||||
| Stock-based compensation expense | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Accounts receivable | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from stock options exercised | |||||
| Repurchase of shares for tax withholdings | |||||
| Proceeds from issuance of term loan, net of issuance costs paid to lender | |||||
| Payment of debt issuance costs | |||||
| Proceeds from public offering, net of underwriters' discounts | |||||
| Proceeds from at the market offering, net of sales commission | |||||
| Payment of offering costs | |||||
| Net cash provided by financing activities | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, at beginning of period | |||||
| Cash, cash equivalents and restricted cash, at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Deferred offering costs not yet paid | |||||
| Debt issuance costs not yet paid | |||||
| Recognition of derivative liability associated with contingently issuable warrants | |||||
| Issuance of warrants in connection with term loan financing | |||||
Loading...